129 related articles for article (PubMed ID: 3555791)
1. Phase II trial of aminothiadiazole in previously treated and untreated patients with advanced colorectal carcinoma: an Illinois Cancer Council Trial.
Locker GY; Khandekar J; Krauss S; Reisel H; Hoeltgen T; Wolter J; Haid M; Hoffman R; Blough R; Johnson C
Cancer Treat Rep; 1987 Jun; 71(6):649-50. PubMed ID: 3555791
[TBL] [Abstract][Full Text] [Related]
2. Phase II study of esorubicin in patients with advanced colorectal carcinoma and no prior chemotherapy: an Illinois Cancer Council Trial.
Locker GY; Hoeltgen T; Kilton L; Krauss S; McNamara M; Blough R; Johnson C
Cancer Treat Rep; 1987; 71(7-8):765-6. PubMed ID: 3300969
[No Abstract] [Full Text] [Related]
3. Phase II evaluation of metoprine with leucovorin rescue in patients with advanced colorectal carcinoma.
Lynch G; Currie V; Kemeny N
Cancer Clin Trials; 1981; 4(3):281-3. PubMed ID: 6974612
[TBL] [Abstract][Full Text] [Related]
4. Phase II trial of teniposide in previously treated and untreated patients with advanced colorectal carcinoma: an Illinois Cancer Council Trial.
Locker GY; Lanzotti V; Khandekar JD; Sweet D; Shaw J; Bitran J; Gordon L; Krauss S; Johnson C
Cancer Treat Rep; 1986 Feb; 70(2):307-8. PubMed ID: 3948195
[No Abstract] [Full Text] [Related]
5. Phase II trial of mitolactol in previously treated and untreated patients with advanced colorectal cancer: an Illinois Cancer Council trial.
Locker GY; Lanzotti V; Sweet D; Lad T; Khandekar J; Stiff P; Johnson C; Miller S
Cancer Treat Rep; 1984 Oct; 68(10):1303-4. PubMed ID: 6525605
[No Abstract] [Full Text] [Related]
6. Phase II study of chlorozotocin in the treatment of advanced colorectal cancer.
Lawton JO; Giles GR; Hall J; MacAdam A; Hall R; Matheson T; Bird G
Cancer Treat Rep; 1981; 65(1-2):13-15. PubMed ID: 6452945
[TBL] [Abstract][Full Text] [Related]
7. Phase II study of metronidazole therapy for advanced colorectal carcinoma.
Frytak S; Moertel CG; Childs DS; Schutt AJ; Albers JW
Cancer Treat Rep; 1978 Mar; 62(3):483-5. PubMed ID: 348320
[TBL] [Abstract][Full Text] [Related]
8. Combination chemotherapy of cisplatin and 5-FU in advanced colorectal carcinoma.
Dy C; Gil A; Algarra SM; Aparicio LA; Calvo F; Herranz P
Cancer Treat Rep; 1986 Apr; 70(4):465-8. PubMed ID: 3698039
[TBL] [Abstract][Full Text] [Related]
9. Phase II trial of a combination of cyclosphamide, vincristine, and methotrexate in advanced colorectal carcinoma.
Taylor SG; Desai SA; DeWys WD
Cancer Treat Rep; 1978 Aug; 62(8):1203-5. PubMed ID: 356978
[TBL] [Abstract][Full Text] [Related]
10. Phase II trial of iv 6-thioguanine in advanced colorectal carcinoma.
Britell JC; Moertel CG; Kvols LK; O'Connell MJ; Rubin J; Schutt AJ
Cancer Treat Rep; 1981; 65(9-10):909-10. PubMed ID: 7273027
[TBL] [Abstract][Full Text] [Related]
11. Phase II trial of esorubicin in patients with advanced colorectal carcinoma.
Fiore J; Kemeny N; Raymond V; Young C
Cancer Treat Rep; 1986 Oct; 70(10):1241-2. PubMed ID: 3530453
[No Abstract] [Full Text] [Related]
12. Randomized phase II studies in advanced colorectal carcinoma: a North Central Cancer Treatment Group study.
Windschitl H; Scott M; Schutt A; McCormack G; Everson L; Cullinan S; Gerstner J; Krook J; Laurie J; Shreck R
Cancer Treat Rep; 1983 Nov; 67(11):1001-8. PubMed ID: 6640551
[TBL] [Abstract][Full Text] [Related]
13. Phase II study of acivicin in colorectal carcinoma: a National Cancer Institute of Canada study.
Maroun JA; Fields AL; Pater JL; Stewart DJ; Cripps C; Eisenhauer E
Cancer Treat Rep; 1984 Sep; 68(9):1121-3. PubMed ID: 6478451
[TBL] [Abstract][Full Text] [Related]
14. Five-year results of a randomized controlled trial of adjuvant chemotherapy for curatively resected colorectal carcinoma. The Colorectal Cancer Chemotherapy Study Group of Japan.
Jpn J Clin Oncol; 1995 Jun; 25(3):91-103. PubMed ID: 7596054
[TBL] [Abstract][Full Text] [Related]
15. Phase II evaluation of DON (6-diazo-5-oxo-L-norleucine) in patients with advanced colorectal carcinoma.
Lynch G; Kemeny N; Casper E
Am J Clin Oncol; 1982 Oct; 5(5):541-3. PubMed ID: 7180833
[TBL] [Abstract][Full Text] [Related]
16. Phase III study of ICRF-159 versus 5-FU in the treatment of advanced metastatic colorectal carcinoma.
Paul AR; Catalano RB; Engstrom PF
Cancer Treat Rep; 1980; 64(10-11):1047-9. PubMed ID: 7006805
[TBL] [Abstract][Full Text] [Related]
17. Phase II trial of menogaril in patients with advanced colorectal carcinoma: an Illinois Cancer Council trial.
Locker GY; Kilton L; Hoeltgen T; Knop RH; Benson AB; Chernicoff D; Barrett J; Blough R; Johnson C
Cancer Treat Rep; 1987 Sep; 71(9):871-2. PubMed ID: 2957053
[No Abstract] [Full Text] [Related]
18. Phase II study of melphalan in colorectal carcinoma.
DiBenedetto J; Moayeri H; Evans JT; Mittelman A
Cancer Treat Rep; 1978 Sep; 62(9):1401-2. PubMed ID: 688286
[TBL] [Abstract][Full Text] [Related]
19. Phase I-II trial of methyl-GAG in advanced colon cancer. a Southwest Oncology Group pilot study.
Myers JW; Knight WA; Livingston RB; Fabian C; Costanzi J
Cancer Clin Trials; 1981; 4(3):277-9. PubMed ID: 7285275
[TBL] [Abstract][Full Text] [Related]
20. A phase II study of weekly 24-hour infusion of high-dose 5-fluorouracil and leucovorin (HDFL) in the treatment of recurrent or metastatic colorectal cancers.
Yeh KH; Cheng AL; Lin MT; Hong RL; Hsu CH; Lin JF; Chang KJ; Lee PH; Chen YC
Anticancer Res; 1997; 17(5B):3867-71. PubMed ID: 9427794
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]